These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 11331054

  • 41. Hyperkalemia and renal function during monotherapy and dual renin-angiotensin blockade in the community setting.
    Kurnik D, Vesterman-Landes J, Bialik M, Katzir I, Lomnicky Y, Halkin H, Loebstein R.
    Clin Ther; 2011 Apr; 33(4):456-64. PubMed ID: 21635991
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF.
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The safety of spironolactone treatment in patients with heart failure.
    Anton C, Cox AR, Watson RD, Ferner RE.
    J Clin Pharm Ther; 2003 Aug; 28(4):285-7. PubMed ID: 12911680
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Prospective observational study of angiotensin converting enzyme inhibitors-induced hyperkalemia in hospitalized patients with chronic renal failure].
    Ben Mahmoud L, Ghozzi H, Kammoun K, Hakim A, Kharrat M, Ben Hmida M, Jarraya F, Sahnoun Z, Zeghal K, Hachicha J.
    Nephrol Ther; 2013 Apr; 9(2):98-102. PubMed ID: 23022289
    [Abstract] [Full Text] [Related]

  • 49. [Effects of the RALE study. Hyperkalemia following spironolactone treatment].
    Erdmann E.
    Internist (Berl); 2005 Apr; 46(4):466, 468. PubMed ID: 15723149
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
    Dinsdale C, Wani M, Steward J, O'Mahony MS.
    Age Ageing; 2005 Jul; 34(4):395-8. PubMed ID: 15955761
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Diabetes and drug-associated hyperkalemia: effect of potassium monitoring.
    Raebel MA, Ross C, Xu S, Roblin DW, Cheetham C, Blanchette CM, Saylor G, Smith DH.
    J Gen Intern Med; 2010 Apr; 25(4):326-33. PubMed ID: 20087674
    [Abstract] [Full Text] [Related]

  • 56. An investigation of the concomitant use of angiotensin-converting enzyme inhibitors, non-steroidal anti-inflammatory drugs and diuretics.
    Bucsa C, Moga DC, Farcas A, Mogosan C, Dumitrascu DL.
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2938-44. PubMed ID: 26241552
    [Abstract] [Full Text] [Related]

  • 57. Safety of low-dose spironolactone administration in chronic haemodialysis patients.
    Saudan P, Mach F, Perneger T, Schnetzler B, Stoermann C, Fumeaux Z, Rossier M, Martin PY.
    Nephrol Dial Transplant; 2003 Nov; 18(11):2359-63. PubMed ID: 14551366
    [Abstract] [Full Text] [Related]

  • 58. Clinical factors associated with hyperkalemia in patients with congestive heart failure.
    Ramadan FH, Masoodi N, El-Solh AA.
    J Clin Pharm Ther; 2005 Jun; 30(3):233-9. PubMed ID: 15896240
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
    Cruz CS, Cruz LS, Domingues GS, Souza CA.
    Expert Opin Drug Saf; 2005 Jul; 4(4):677-88. PubMed ID: 16011447
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.